Localite at DGPPN Congress 2026 – Advancing Precision Psychiatry with Brain Stimulation Technologies

Localite GmbH is pleased to participate in the DGPPN Congress 2026, one of Europe’s largest and most influential events in psychiatry, psychotherapy, psychosomatics, and neuroscience.

Each year, the congress brings together thousands of psychiatrists, psychotherapists, researchers, and healthcare professionals to discuss the latest developments in prevention, diagnosis, and treatment of mental disorders. As mental health care continues to evolve, innovative technologies such as Transcranial Magnetic Stimulation (TMS) and other non-invasive brain stimulation approaches are becoming increasingly important in clinical practice.

At Localite, we support the advancement of precision psychiatry through innovative TMS neuronavigation and neuronavigation technologies that enable accurate and reproducible brain stimulation treatments. By combining advanced imaging with precision targeting, clinicians can deliver more personalized neuromodulation therapies tailored to individual patient needs.

DGPPN provides a unique platform to discuss the future of psychiatry, neuroscience, and mental health treatment. We look forward to exchanging ideas with clinicians, researchers, and healthcare professionals on the growing role of brain stimulation, neuromodulation, and neurotechnology in modern psychiatric care.

• Join us at DGPPN 2026 to discover how precision brain stimulation and TMS neuronavigation are helping shape the future of mental health treatment.